Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.74 USD | +3.31% | +1.91% | +19.49% |
May. 23 | Norfolk Southern Reaches $310 Million Settlement with DOJ, EPA | MT |
May. 23 | Norfolk Southern Settles Government's Ohio Derailment Probe | DJ |
Strengths
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+23.16% | 479M | B- | ||
+21.17% | 83.46B | C+ | ||
-2.68% | 25.66B | C+ | ||
+3.31% | 17.91B | A- | ||
-15.05% | 16.54B | B | ||
+0.57% | 15.43B | A- | ||
+73.53% | 13.46B | C- | ||
+74.37% | 12.78B | C+ | ||
+39.22% | 12.6B | B- | ||
+1.03% | 12.55B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CYH Stock
- Ratings Community Health Systems, Inc.